SCHEMBL7104854

SCHEMBL7104854

CCOC(=O)c1cccc(Nc2nc(Nc3ccc(C(=O)O)cc3)c3nc[nH]c3n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
KDM4E B2RXH2 4/20 0.56
RAB9A P51151 3/20 0.56
NPC1 O15118 2/20 0.56
BRAF P15056 1/20 0.55
TP53 P04637 5/20 0.49
MAPT P10636 5/20 0.49
ALK Q9UM73 1/20 0.49
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
THRB P10828 2/20 0.48
TSHR P16473 1/20 0.47
RECQL P46063 1/20 0.47
LMNA P02545 3/20 0.47
POLB P06746 1/20 0.47
CREBBP Q92793 1/20 0.47
HPGD P15428 3/20 0.46
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 2/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893816 0.95 SMN1; SMN2 (0.59) SMN1; SMN2KDM4ERAB9ANPC1BRAF
SCHEMBL7107687 0.92 ALK (0.57) SMN1; SMN2KDM4ERAB9ANPC1TP53
SCHEMBL4894962 0.88 BRAF (0.54) SMN1; SMN2KDM4ERAB9ANPC1BRAF
SCHEMBL4898620 0.87 ALK (0.61) SMN1; SMN2KDM4ERAB9ANPC1TP53
SCHEMBL4901287 0.84 RAB9A (0.50) SMN1; SMN2KDM4ERAB9ANPC1BRAF
SCHEMBL4898607 0.83 BRAF (0.61) SMN1; SMN2KDM4ERAB9ANPC1BRAF
SCHEMBL7108322 0.83 GSK3B (0.50) SMN1; SMN2RAB9ANPC1BRAFMAPT
SCHEMBL4892691 0.81 ALK (0.55) SMN1; SMN2KDM4ERAB9ANPC1TP53
SCHEMBL4889912 0.80 MAPKAPK2 (0.55) SMN1; SMN2KDM4ERAB9ANPC1BRAF
SCHEMBL4889926 0.80 MAPKAPK2 (0.55) SMN1; SMN2KDM4ERAB9ANPC1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP claimed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO claimed
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed